PUBLISHER: IMARC | PRODUCT CODE: 1347691
PUBLISHER: IMARC | PRODUCT CODE: 1347691
High Content Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Overview:
The global high content screening market size reached US$ 1.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.4% during 2023-2028.
High content screening (HCS), also known as high-content analysis (HCA), is an automated microscopy method of identifying cellular phenotype and biological deviations. It assists in determining whether a drug candidate modifies the disease course and identifying micro-molecules such as peptides or RNAi that alter the cell morphology and phenotype. It is an advanced approach to cell-based screening in drug discovery, which combines the automated recording of multicolor fluorescence imaging and high-throughput quantitative data analysis. It allows professionals to screen and evaluate the activity of compounds on multiple epigenetic marks. As a result, HCS is widely used in pharmaceutical and biotechnology companies, academic and government institutes, and contract research organizations (CROS).
The increasing prevalence of chronic disorders and neurodegenerative diseases, such as Alzheimer's and Parkinson's, represents one of the major factors positively influencing the demand for HCS around the world. In addition, the rising aging population, which is more prone to such ailments, is contributing to the market growth. Apart from this, leading players are introducing innovative HCS equipment that is integrated with software platforms and artificial intelligence (AI) systems to improve the visualization capabilities of the screening systems. It can also be attributed to the development of automated systems for analyzing cell separation and scalability, which has further improved the adoption of HCS technology. Furthermore, they find extensive application in the pharmaceutical industry due to the escalating need for an affordable drug discovery system. Besides this, governing agencies of numerous countries are considerably investing in the research and development (R&D) of advanced screening systems, along with significant improvement in the healthcare infrastructure, which is creating a positive market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global high content screening market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end-user.
Breakup by Product:
Instruments
Cell Imaging and Analysis Systems
Flow Cytometers
Consumables
Reagents & Assay Kits
Microplates
Other Consumables
Software
Services
Accessories
Instruments dominate the market due to advances in instrumentation and automation techniques with advanced visualization capability and enhanced software platforms.
Breakup by Application:
Target Identification and Validation
Primary Screening and Secondary Screening
Toxicity Studies
Compound Profiling
Other Applications
Primary screening and secondary screening currently dominates the market as primary screening helps in determining the microorganisms and organic acid in cells, whereas secondary screening assists in obtaining the quantitative and qualitative information about the cells, desired organisms or strains.
Breakup by End-User:
Pharmaceutical and Biotechnology Companies
Academic and Government Institutes
Contract Research Organizations (CROs)
High content screening (HCS) is widely utilized in pharmaceutical and biotechnology companies for various clinical and preclinical studies.
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America holds the majority of the global high content screening share due to the increasing drug discovery research in the region.
Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Biotek Instruments Inc., Danaher Corporation, GE Healthcare, Merck Millipore, Perkinelmer Inc., Tecan Group Ltd., Thermo Fisher Scientific and Yokogawa Electric Corporation.
Key Questions Answered in This Report:
- How has the global high content screening market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global high content screening market?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global high content screening market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global High Content Screening Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Instruments
- 6.1.1 Market Trends
- 6.1.2 Major Types
- 6.1.2.1 Cell Imaging and Analysis Systems
- 6.1.2.2 Flow Cytometers
- 6.1.3 Market Forecast
- 6.2 Consumables
- 6.2.1 Market Trends
- 6.2.2 Major Types
- 6.2.2.1 Reagents & Assay Kits
- 6.2.2.2 Microplates
- 6.2.2.3 Others
- 6.2.3 Market Forecast
- 6.3 Software
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Services
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Accessories
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Application
- 7.1 Target Identification and Validation
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Primary Screening and Secondary Screening
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Toxicity Studies
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Compound Profiling
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by End-User
- 8.1 Pharmaceutical and Biotechnology Companies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Academic and Government Institutes
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Contract Research Organizations (CROs)
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Indicators
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Becton, Dickinson and Company
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Bio-Rad Laboratories Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Biotek Instruments Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Danaher Corporation
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 GE Healthcare
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Merck Millipore
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Perkinelmer Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Tecan Group Ltd.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Thermo Fisher Scientific
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Yokogawa Electric Corporation
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.1 Becton, Dickinson and Company
List of Figures
- Figure 1: Global: High Content Screening Market: Major Drivers and Challenges
- Figure 2: Global: High Content Screening Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: High Content Screening Market: Breakup by Product (in %), 2022
- Figure 4: Global: High Content Screening Market: Breakup by Application (in %), 2022
- Figure 5: Global: High Content Screening Market: Breakup by End-User (in %), 2022
- Figure 6: Global: High Content Screening Market: Breakup by Region (in %), 2022
- Figure 7: Global: High Content Screening Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 8: Global: High Content Screening (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 9: Global: High Content Screening (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 10: Global: High Content Screening (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: High Content Screening (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: High Content Screening (Software) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: High Content Screening (Software) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: High Content Screening (Services) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: High Content Screening (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: High Content Screening (Accessories) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: High Content Screening (Accessories) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: High Content Screening (Target Identification and Validation) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: High Content Screening (Target Identification and Validation) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: High Content Screening (Primary Screening and Secondary Screening) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: High Content Screening (Primary Screening and Secondary Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: High Content Screening (Toxicity Studies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: High Content Screening (Toxicity Studies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Global: High Content Screening (Compound Profiling) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Global: High Content Screening (Compound Profiling) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: Global: High Content Screening (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: Global: High Content Screening (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: Global: High Content Screening (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: Global: High Content Screening (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: Global: High Content Screening (Academic and Government Institutes) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: Global: High Content Screening (Academic and Government Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: Global: High Content Screening (Contract Research Organizations-CROs) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: Global: High Content Screening (Contract Research Organizations-CROs) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: North America: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: North America: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: United States: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: United States: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: Canada: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: Canada: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: Asia Pacific: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: Asia Pacific: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: China: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: China: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: Japan: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: Japan: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: India: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: India: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: South Korea: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: South Korea: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: Australia: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: Australia: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: Indonesia: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: Indonesia: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: Others: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: Others: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: Europe: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: Europe: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: Germany: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: Germany: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: France: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: France: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: United Kingdom: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: United Kingdom: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Italy: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Italy: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: Spain: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: Spain: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: Russia: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: Russia: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Others: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 71: Others: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 72: Latin America: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 73: Latin America: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 74: Brazil: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 75: Brazil: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 76: Mexico: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 77: Mexico: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 78: Others: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 79: Others: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 80: Middle East and Africa: High Content Screening Market: Sales Value (in Million US$), 2017 & 2022
- Figure 81: Middle East and Africa: High Content Screening Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 82: Global: High Content Screening Industry: SWOT Analysis
- Figure 83: Global: High Content Screening Industry: Value Chain Analysis
- Figure 84: Global: High Content Screening Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: High Content Screening Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: High Content Screening Market Forecast: Breakup by Product (in Million US$), 2023-2028
- Table 3: Global: High Content Screening Market Forecast: Breakup by Application (in Million US$), 2023-2028
- Table 4: Global: High Content Screening Market Forecast: Breakup by End-User (in Million US$), 2023-2028
- Table 5: Global: High Content Screening Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 6: Global: High Content Screening Market: Competitive Structure
- Table 7: Global: High Content Screening Market: Key Players
